Latest stock market podcasts

In this episode of From the Helm, Grady sits down with Mesoblast Director Silviu Itescu, to unpack the recent approval and launch of their Ryoncil drug for children, their outlook for the next 12 months in capturing the adult market, and their extensive pipeline of further products.